The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer.
Saved in:
| Title: | The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer. |
|---|---|
| Authors: | Michaelis KA; Medical Scientist Training Program, Oregon Health & Science University, Portland, OR, USA.; Brenden-Colson Center for Pancreatic Care, Oregon Health & Science University, Portland, OR, USA., Norgard MA; Papé Family Pediatric Research Institute, Oregon Health & Science University, Portland, OR, USA., Zhu X; Papé Family Pediatric Research Institute, Oregon Health & Science University, Portland, OR, USA., Levasseur PR; Papé Family Pediatric Research Institute, Oregon Health & Science University, Portland, OR, USA., Sivagnanam S; Department of Computational Biology, Oregon Health & Science University, Portland, OR, USA., Liudahl SM; Department of Cell, Developmental and Cancer Biology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA., Burfeind KG; Medical Scientist Training Program, Oregon Health & Science University, Portland, OR, USA., Olson B; Medical Scientist Training Program, Oregon Health & Science University, Portland, OR, USA., Pelz KR; Papé Family Pediatric Research Institute, Oregon Health & Science University, Portland, OR, USA., Angeles Ramos DM; Papé Family Pediatric Research Institute, Oregon Health & Science University, Portland, OR, USA., Maurer HC; Departments of Medicine and Pathology and Cell Biology, Columbia University Medical Center, New York, NY, USA., Olive KP; Departments of Medicine and Pathology and Cell Biology, Columbia University Medical Center, New York, NY, USA., Coussens LM; Department of Cell, Developmental and Cancer Biology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA., Morgan TK; Department of Pathology, Oregon Health & Science University, Portland, OR, USA., Marks DL; Brenden-Colson Center for Pancreatic Care, Oregon Health & Science University, Portland, OR, USA. marksd@ohsu.edu.; Papé Family Pediatric Research Institute, Oregon Health & Science University, Portland, OR, USA. marksd@ohsu.edu. |
| Source: | Nature communications [Nat Commun] 2019 Oct 15; Vol. 10 (1), pp. 4682. Date of Electronic Publication: 2019 Oct 15. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 31615993 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Michaelis+KA%22">Michaelis KA</searchLink>; Medical Scientist Training Program, Oregon Health & Science University, Portland, OR, USA.; Brenden-Colson Center for Pancreatic Care, Oregon Health & Science University, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Norgard+MA%22">Norgard MA</searchLink>; Papé Family Pediatric Research Institute, Oregon Health & Science University, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Zhu+X%22">Zhu X</searchLink>; Papé Family Pediatric Research Institute, Oregon Health & Science University, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Levasseur+PR%22">Levasseur PR</searchLink>; Papé Family Pediatric Research Institute, Oregon Health & Science University, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Sivagnanam+S%22">Sivagnanam S</searchLink>; Department of Computational Biology, Oregon Health & Science University, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Liudahl+SM%22">Liudahl SM</searchLink>; Department of Cell, Developmental and Cancer Biology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Burfeind+KG%22">Burfeind KG</searchLink>; Medical Scientist Training Program, Oregon Health & Science University, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Olson+B%22">Olson B</searchLink>; Medical Scientist Training Program, Oregon Health & Science University, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Pelz+KR%22">Pelz KR</searchLink>; Papé Family Pediatric Research Institute, Oregon Health & Science University, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Angeles+Ramos+DM%22">Angeles Ramos DM</searchLink>; Papé Family Pediatric Research Institute, Oregon Health & Science University, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Maurer+HC%22">Maurer HC</searchLink>; Departments of Medicine and Pathology and Cell Biology, Columbia University Medical Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Olive+KP%22">Olive KP</searchLink>; Departments of Medicine and Pathology and Cell Biology, Columbia University Medical Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Coussens+LM%22">Coussens LM</searchLink>; Department of Cell, Developmental and Cancer Biology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Morgan+TK%22">Morgan TK</searchLink>; Department of Pathology, Oregon Health & Science University, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Marks+DL%22">Marks DL</searchLink>; Brenden-Colson Center for Pancreatic Care, Oregon Health & Science University, Portland, OR, USA. marksd@ohsu.edu.; Papé Family Pediatric Research Institute, Oregon Health & Science University, Portland, OR, USA. marksd@ohsu.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2019 Oct 15; Vol. 10 (1), pp. 4682. <i>Date of Electronic Publication: </i>2019 Oct 15. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31615993 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41467-019-12657-w Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 4682 Titles: – TitleFull: The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Michaelis KA – PersonEntity: Name: NameFull: Norgard MA – PersonEntity: Name: NameFull: Zhu X – PersonEntity: Name: NameFull: Levasseur PR – PersonEntity: Name: NameFull: Sivagnanam S – PersonEntity: Name: NameFull: Liudahl SM – PersonEntity: Name: NameFull: Burfeind KG – PersonEntity: Name: NameFull: Olson B – PersonEntity: Name: NameFull: Pelz KR – PersonEntity: Name: NameFull: Angeles Ramos DM – PersonEntity: Name: NameFull: Maurer HC – PersonEntity: Name: NameFull: Olive KP – PersonEntity: Name: NameFull: Coussens LM – PersonEntity: Name: NameFull: Morgan TK – PersonEntity: Name: NameFull: Marks DL IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 10 Text: 2019 Oct 15 Type: published Y: 2019 Identifiers: – Type: issn-electronic Value: 2041-1723 Numbering: – Type: volume Value: 10 – Type: issue Value: 1 Titles: – TitleFull: Nature communications Type: main |
| ResultId | 1 |